Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 108

1.

Lower urinary tract symptoms, benign prostatic hyperplasia/benign prostatic enlargement and erectile dysfunction: Are these conditions related to vascular dysfunction?

Shimizu S, Tsounapi P, Shimizu T, Honda M, Inoue K, Dimitriadis F, Saito M.

Int J Urol. 2014 Jun 15. doi: 10.1111/iju.12501. [Epub ahead of print]

PMID:
24930630
[PubMed - as supplied by publisher]
2.

Impact of phytotherapy on utility scores for 5 benign prostatic hyperplasia/lower urinary tract symptoms health states.

Dedhia RC, Calhoun E, McVary KT.

J Urol. 2008 Jan;179(1):220-5. Epub 2007 Nov 14.

PMID:
18001791
[PubMed - indexed for MEDLINE]
3.

Direct effects of tadalafil on lower urinary tract symptoms versus indirect effects mediated through erectile dysfunction symptom improvement: integrated data analyses from 4 placebo controlled clinical studies.

Brock GB, McVary KT, Roehrborn CG, Watts S, Ni X, Viktrup L, Wong DG, Donatucci C.

J Urol. 2014 Feb;191(2):405-11. doi: 10.1016/j.juro.2013.09.057. Epub 2013 Oct 1.

PMID:
24096120
[PubMed - indexed for MEDLINE]
4.

Efficacy and safety of the coadministration of tadalafil once daily with finasteride for 6 months in men with lower urinary tract symptoms and prostatic enlargement secondary to benign prostatic hyperplasia.

Casabé A, Roehrborn CG, Da Pozzo LF, Zepeda S, Henderson RJ, Sorsaburu S, Henneges C, Wong DG, Viktrup L.

J Urol. 2014 Mar;191(3):727-33. doi: 10.1016/j.juro.2013.09.059. Epub 2013 Oct 2.

PMID:
24096118
[PubMed - indexed for MEDLINE]
5.

A new experimental rat model of erectile dysfunction and lower urinary tract symptoms associated with benign prostatic hyperplasia: the testosterone-supplemented spontaneously hypertensive rat.

Oudot A, Oger S, Behr-Roussel D, Caisey S, Bernabé J, Alexandre L, Giuliano F.

BJU Int. 2012 Nov;110(9):1352-8. doi: 10.1111/j.1464-410X.2012.11085.x. Epub 2012 Mar 27.

PMID:
22448674
[PubMed - indexed for MEDLINE]
6.

Modifiable risk factors for benign prostatic hyperplasia and lower urinary tract symptoms: new approaches to old problems.

Parsons JK.

J Urol. 2007 Aug;178(2):395-401. Epub 2007 Jun 11. Review.

PMID:
17561143
[PubMed - indexed for MEDLINE]
7.
8.

Diabetes and benign prostatic hyperplasia/lower urinary tract symptoms--what do we know?

Sarma AV, Parsons JK, McVary K, Wei JT.

J Urol. 2009 Dec;182(6 Suppl):S32-7. doi: 10.1016/j.juro.2009.07.088. Review.

PMID:
19846144
[PubMed - indexed for MEDLINE]
9.

Risk factors for lower urinary tract symptoms suggestive of benign prostatic hyperplasia in a community based population of healthy aging men: the Krimpen Study.

Kok ET, Schouten BW, Bohnen AM, Groeneveld FP, Thomas S, Bosch JL.

J Urol. 2009 Feb;181(2):710-6. doi: 10.1016/j.juro.2008.10.025. Epub 2008 Dec 16.

PMID:
19091352
[PubMed - indexed for MEDLINE]
10.

The prostatic urethral lift for the treatment of lower urinary tract symptoms associated with prostate enlargement due to benign prostatic hyperplasia: the L.I.F.T. Study.

Roehrborn CG, Gange SN, Shore ND, Giddens JL, Bolton DM, Cowan BE, Brown BT, McVary KT, Te AE, Gholami SS, Rashid P, Moseley WG, Chin PT, Dowling WT, Freedman SJ, Incze PF, Coffield KS, Borges FD, Rukstalis DB.

J Urol. 2013 Dec;190(6):2161-7. doi: 10.1016/j.juro.2013.05.116. Epub 2013 Jun 11.

PMID:
23764081
[PubMed - indexed for MEDLINE]
11.

Critical analysis of the relationship between sexual dysfunctions and lower urinary tract symptoms due to benign prostatic hyperplasia.

Gacci M, Eardley I, Giuliano F, Hatzichristou D, Kaplan SA, Maggi M, McVary KT, Mirone V, Porst H, Roehrborn CG.

Eur Urol. 2011 Oct;60(4):809-25. doi: 10.1016/j.eururo.2011.06.037. Epub 2011 Jun 29. Review.

PMID:
21726934
[PubMed - indexed for MEDLINE]
12.

Pathogenic mechanisms linking benign prostatic hyperplasia, lower urinary tract symptoms and erectile dysfunction.

Glina S, Glina FP.

Ther Adv Urol. 2013 Aug;5(4):211-8. doi: 10.1177/1756287213488236.

PMID:
23904860
[PubMed]
Free PMC Article
13.

Tadalafil administered once daily for lower urinary tract symptoms secondary to benign prostatic hyperplasia: a dose finding study.

Roehrborn CG, McVary KT, Elion-Mboussa A, Viktrup L.

J Urol. 2008 Oct;180(4):1228-34. doi: 10.1016/j.juro.2008.06.079. Epub 2008 Aug 22.

PMID:
18722631
[PubMed - indexed for MEDLINE]
15.

Tadalafil relieves lower urinary tract symptoms secondary to benign prostatic hyperplasia.

McVary KT, Roehrborn CG, Kaminetsky JC, Auerbach SM, Wachs B, Young JM, Esler A, Sides GD, Denes BS.

J Urol. 2007 Apr;177(4):1401-7.

PMID:
17382741
[PubMed - indexed for MEDLINE]
16.

Sexual dysfunction in 1,274 European men suffering from lower urinary tract symptoms.

Vallancien G, Emberton M, Harving N, van Moorselaar RJ; Alf-One Study Group.

J Urol. 2003 Jun;169(6):2257-61.

PMID:
12771764
[PubMed - indexed for MEDLINE]
17.

Latest treatment for lower urinary tract dysfunction: therapeutic agents and mechanism of action.

Yamaguchi O.

Int J Urol. 2013 Jan;20(1):28-39. doi: 10.1111/iju.12008. Epub 2012 Nov 28. Review.

PMID:
23190275
[PubMed - indexed for MEDLINE]
18.

[Sexual dysfunctions linked with prostatic diseases].

Rouprêt M, Seisen T, De La Taille A, Desgrandchamps F.

Prog Urol. 2012 Jun;22 Suppl 1:S14-20. doi: 10.1016/S1166-7087(12)70030-1. French.

PMID:
22770495
[PubMed - indexed for MEDLINE]
19.

Genetic sequence variants are associated with severity of lower urinary tract symptoms and prostate cancer susceptibility.

Helfand BT, Hu Q, Loeb S, McVary KT, Catalona WJ.

J Urol. 2013 Mar;189(3):845-8. doi: 10.1016/j.juro.2012.11.044. Epub 2012 Nov 13.

PMID:
23159463
[PubMed - indexed for MEDLINE]
20.

Treatment of lower urinary tract symptoms in benign prostatic hyperplasia and its impact on sexual function.

Miner M, Rosenberg MT, Perelman MA.

Clin Ther. 2006 Jan;28(1):13-25. Review.

PMID:
16490576
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk